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Abstract : Background : Since diaphragm passivity induces oxidative stress that leads to rapid atrophy of di-
aphragm, we investigated the effect of controlled ventilation on diaphragm thickness during assist-control 
ventilation (ACV). Methods : Previously, we measured end-expiratory diaphragm thickness (Tdiee) of patients 
mechanically ventilated for more than 48 hours on days 1, 3, 5 and 7 after the start of ventilation. We retrospec-
tively investigated the proportion of controlled ventilation during the initial 48-hour ACV (CV48%). Patients were 
classified according to CV48% : Low group, less than 25% ; High group, higher than 25%. Results : Of 56 patients 
under pressure-control ACV, Tdiee increased more than 10% in 6 patients (11%), unchanged in 8 patients (14%) 
and decreased more than 10% in 42 patients (75%). During the first week of ventilation, Tdiee decreased in both 
groups : Low (difference, -7.4% ; 95% confidence interval [CI], -10.1% to -4.6% ; p < 0.001) and High group (differ-
ence, -5.2% ; 95% CI, -8.5% to -2.0% ; p = 0.049). Maximum Tdiee variation from baseline did not differ between Low 
(-15.8% ; interquartile range [IQR], -22.3 to -1.5) and High group (-16.7% ; IQR, -22.6 to -11.1, p = 0.676). Conclu-
sions : During ACV, maximum variation in Tdiee was not associated with proportion of controlled ventilation 
higher than 25%. J. Med. Invest. 67 : 332-337, August, 2020
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INTRODUCTION
 
It has been established that mechanical ventilation can cause 
diaphragm dysfunction. (ventilator-induced diaphragm dysfunc-
tion : VIDD) (1) which is associated with higher mortality in in-
tensive care units (ICU) and hospitals (2, 3). The most important 
cause of VIDD and diaphragm atrophy is disuse owing to the 
suppression of inspiratory effort (4, 5). In animal experiments, 
short periods of passive controlled mechanical ventilation (CMV) 
has induced oxidative stress that leads to protein degradation, 
resulting in diaphragm-muscle atrophy and weakness (6-8). In 
one of the few human investigations, Levine et al. (9) reported 
that prolonged diaphragmatic inactivity in brain-dead organ 
donors was associated with marked atrophy of diaphragm myofi-
bers. Furthermore, these detrimental effects of CMV on the dia-
phragm could be largely ameliorated by assist-control ventilation 
(ACV) (10), intermittent spontaneous breathing during CMV 
(11), pressure support ventilation (PSV) (12, 13), and adaptive 
support ventilation (14). Consequently, to preserve spontaneous 
effort, most critically ill patients who require mechanical ventila-
tion receive assisted and spontaneous modalities (1, 15).
ACV is the most frequently applied mode during critical care, 
with 60% of mechanically ventilated patients receiving ACV 
(16, 17). In ACV, mechanical ventilation can be triggered by 
the ventilator (controlled ventilation) or the patient (assisted 
ventilation) (18). During controlled ventilation, triggering occurs 
after detection of a certain period without inspiratory effort ; 
when this happens, diaphragm contraction does not precede the 
mechanical ventilation. Theoretically, the more the proportion 
of controlled ventilation increases during ACV, the more the 
diaphragm is disused. Marin-Corral et al. (19) recently observed 
Maastricht III organ donors who can stimulate their diaphragm 
spent 41% of ventilation time in assisted and spontaneous 
modalities. This resulted in less diaphragm myofiber damage 
than in brain-dead organ donors relying on full support. In 
most studies cited above (6-15), diaphragm atrophy from disuse, 
however, has been evaluated with traditional CMV, which ren-
ders the diaphragm completely inactive, or by comparing CMV 
with partially assisted mechanical ventilation. To the best of 
our knowledge, our clinical study is the first to investigate the 
effects on diaphragm atrophy, diagnosed by ultrasonography, of 
controlled ventilation through the course of a single ventilation 
mode, ACV.
We aimed to test the hypothesis that a higher proportion of 
controlled ventilation during the initial 48 hours of ACV would 
correlate with greater diaphragm atrophy among general criti-
cally ill patients. 
METHODS
We conducted this study in a university hospital. Ethical 
approval for this study was provided by the ethics committee of 
Tokushima University Hospital (protocol number 3220). Written 
informed consent from each patient was waived as approved 
by the committee. This study was registered on a clinical trial 
(UMIN clinical trial registry : 000032944).
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Study design and patients
This study is a post-hoc analysis of our prospective observa-
tional study (20) which evaluated changes in diaphragm and in-
tercostal muscle thickness in mechanically ventilated patients. 
In that study, we recruited adult patients who were consecutively 
admitted to the ICU and expected to require mechanical ventila-
tion for more than 48 hours. Exclusion criteria were : age under 
18 years ; trauma or chest tube at the measurement point ; and 
diagnosis of primary neuromuscular disease. Among this pop-
ulation of the previous study, we selected patients who were on 
pressure-control ACV throughout at least the first 54 hours of 
mechanical ventilation, and also excluded patients who were 
continuously paralyzed with neuromuscular blocking agents. 
Measurement of diaphragm thickness
In the initial study (20), on days 1, 3, 5 and 7 after the start 
of mechanical ventilation, we used ultrasonography to measure 
diaphragm thickness at peak inspiration and end-expiration 
(Tdiee). Diaphragm thickening was calculated for each measure-
ment as follows : Thickening fraction (%) = [(thickness at peak 
inspiration – thickness at end-expiration) / thickness at end-ex-
piration] × 100. Data collection was discontinued, whichever 
occurs first, at extubation, at patient discharge from the ICU, 
or at death. Measurement procedures are fully detailed in our 
previous study. In brief, referring to previously reported meth-
ods, measurement was performed using B mode ultrasound with 
the liner transducer perpendicularly placed on the right chest 
wall at the zone of apposition (21). Of note, each recording was 
performed by the same investigator and actual measurement 
of diaphragm thickness was retrospectively done by the same 
investigator with the stored images in order to blind the data 
analysis from each patient’s status.
Proportion of controlled ventilation
Reviewing patient charts, we retrospectively calculated the 
proportions of controlled ventilation and assisted ventilation 
during the initial 48 hours of ACV. To eliminate the possible 
effects of neuromuscular blocking agents that might have been 
used during tracheal intubation or in the operating theater, we 
focused on the 48-hour-period starting 6 hours after the start of 
mechanical ventilation in the ICU. That is why inclusion criteria 
required ICU patients who were on ACV for more than 54 hours. 
Actual respiratory frequency is automatically recorded by the 
minute in our electrical system (PrimeGaia, Nihon Kohden, 
Tokyo, Japan). Set values for respiratory rate were manually 
entered into the same system by bedside nurses. While actual 
respiratory frequency was equal to the set value for respiratory 
rate, we assumed that mechanical breaths delivered in the min-
ute were all controlled ventilation triggered by the time. While 
actual respiratory frequency was greater than the set value for 
respiratory rate, mechanical breaths delivered in the minute 
were all considered as assisted ventilation triggered by the 
patient. Then, we calculated the proportion of controlled ventila-
tion during the initial 48 hours of ACV (CV48%) according to the 
formula : CV48% (%) = [total minutes of controlled ventilation / 48 
× 60] × 100.
Endpoints of the study
The primary endpoints of this study were the direction and 
maximum variation in Tdiee during mechanical ventilation. 
According to median CV48%, we assigned patients to either of 
two groups and performed intergroup comparison of direction 
and maximum variation in Tdiee. Secondary endpoints were 
duration of mechanical ventilation, incidence of reintubation and 
tracheostomy, and ICU mortality.
Clinical data collection
Demographic data, APACHE (acute physiology and chronic 
health evaluation) II score on admission to the ICU, reason for 
mechanical ventilation and clinical outcomes were gathered 
from medical charts. Then, for the initial 48-hour period of ACV, 
we collected the following physiological and ventilator variables : 
set values for respiratory rate ; actual respiratory frequen-
cy ; plateau pressure ; positive end-expiratory pressure (PEEP) ; 
tidal volume ; and arterial blood gas analysis.
Statistical analysis
Continuous data are presented as medians with interquartile 
range (IQR), whereas categorical variables are expressed as 
numbers and percentages. Direction of changes in Tdiee over time 
were analyzed in each group by repeated measures of analysis of 
variance with multiple comparisons to reveal effects over time. 
Differences between continuous variables, that is maximum 
variation in Tdiee, thickening fraction, ventilatory and physi-
ologic variables, and duration of mechanical ventilation were 
assessed using t tests or Mann-Whitney U tests. Categorical 
variables, that is, incidence of reintubation, tracheostomy, and 
death in the ICU, were assessed as appropriate with chi-squared 
tests or Fisher exact tests. Statistical calculations were carried 
out with statistics software (SPSS, version 26, SPSS Inc., Chica-
go, IL). P < 0.05 was considered statistically significant.
RESULTS
From the 80 patients in the preliminary study, we selected 
the 64 patients who were on pressure-control ACV throughout 
at least the first 54 hours of mechanical ventilation. We then 
excluded 8 patients who had been continuously paralyzed with 
neuromuscular blocking agents, and finally analyzed valid data 
from 56 patients (Fig. 1). Assessing median CV48% as 24.9%, 
we assigned patients to either of two groups : Low group, CV48% 
less than 25% ; High group, CV48% more-than-or-equal-to 25%. 
Table 1 shows the characteristics of the Low and High groups. 
The most frequent reason for mechanical ventilation was acute 
respiratory failure (34%) for Low group and post-operative care 
(30%) for High group.
Figure 1.　Flow chart of study participants.
PC-ACV, pressure-control assist-control ventilation ; PSV, pressure 
support ventilation.
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Diaphragm thickness was measured in 100%, 100%, 73% 
and 43% of patients on days 1, 3, 5 and 7, respectively. Tdiee was 
2.1 mm [IQR, 1.6 to 2.5], 1.9 mm [IQR, 1.5 to 2.5], 1.8 mm [IQR, 
1.6 to 2.5] and 2.0 mm [IQR, 1.4 to 2.7], and thickening fraction 
was 8.3% [IQR, 4.0 to 17.1], 8.3% [IQR, 4.9 to 12.4], 6.9% [IQR, 
3.2 to 16.2] and 5.6% [IQR, 0.0 to 10.6] on days 1, 3, 5 and 7, re-
spectively. Tdiee increased by more than 10% from the baseline in 
6 patients (11%), unchanged without a 10% increase or decrease 
in 8 patients (14%) and decreased by more than 10% in 42 pa-
tients (75%). Primary and secondary outcomes are summarized 
in Fig. 2 and Table 2. Over the first week of mechanical ventila-
tion, Tdiee decreased in both Low group (difference, -7.4% ; 95% 
confidence interval [CI], -10.1% to -4.6% ; p < 0.001) and High 
group (difference, -5.2% ; 95% CI, -8.5% to -2.0% ; p = 0.049) (Fig. 
2). Maximum variation in Tdiee from the baseline showed no 
intergroup difference (Low, -15.8% [IQR, -22.3 to -1.5] vs. High, 
-16.7% [IQR, -22.6 to -11.1], p = 0.676). There was no statistically 
significant intergroup difference in duration of mechanical ven-
tilation, incidence of reintubation and tracheostomy, and ICU 
mortality (Table. 2).
Table 3 shows ventilation and physiological variables during 
the initial 48 hours of ACV. Set value for respiratory rate was 
significantly lower in Low group than in High group (13.6 per 
min [IQR, 12.2 to 15.1] vs. 16.4 per min [IQR, 14.4 to 18.9], p 
= 0.003). CV48% was 5.1% [IQR, 1.6 to 13.7] in Low group and 
53.8% [IQR, 36.4 to 61.6] in High group (p < 0.001). Tidal volume 
was significantly greater in Low group than in High group (9.1 
mL / kg predicted body weight (PBW) [IQR, 7.7 to 10.1] vs. 7.8 
mL / kg PBW [IQR, 7.1 to 8.8], p = 0.029) ; this was despite lower 
plateau pressure (18.9 cmH2O [IQR, 16.7 to 21.4] vs. 21.1 cmH2O 
[IQR, 18.9 to 22.7], p = 0.017) and PEEP (7.8 cmH2O [IQR, 6.0 
to 8.4] vs. 8.0 cmH2O [IQR, 7.2 to 11.0], p = 0.030). PaO2 / FIO2ra-
tio were similar in both groups. In Low group, pH was slightly 
greater than in High group, although variables in both groups 
were within the normal range (7.44 [IQR, 7.41 to 7.47] vs. 7.41 
[IQR, 7.34 to 7.43], p = 0.003). Thickening fraction did not differ 
between Low and High group (12.5% [IQR, 8.3 to 22.5] vs. 17.4% 
[IQR, 11.1 to 22.2], p = 0.367).
 





Age, yr 74 (63 – 80) 66 (5 – 73)
Male, n (%) 18 (62) 17 (63)
Height, cm 158 (155  – 163) 160 (152 – 170)
Weight, kg 58 (48 –  69) 61 (51 – 69)
APACHE II score 27 (21 – 32) 22 (15 – 28)
Reason for mechanical ventilation, n (%)
Acute respiratory failure 10 (34) 4 (15)
Stroke 5 (17) 2 (7)
Post CPR 4 (14) 3 (11)
Post-operative care 4 (14) 8 (30)
Sepsis / septic shock 3 (10) 4 (15)
Acute heart failure 2 (7) 4 (15)
Others 1 (4) 2 (7)
Data are expressed as median (interquartile range). APACHE, 
acute physiology and chronic health evaluation ; CPR, cardio-pul-
monary resuscitation.
Figure 2.　Changes in mean end-expiratory diaphragm thickness 
over time during assist-control ventilation in Low and High group.
Error bars indicate 95% confidence intervals. *P < 0.05 vs. day 1.
Table 2.　Primary and secondary outcomes





    Maximum variation in Tdiee, % -15.8 (-22.3 – -1.5) -16.7 (-22.6 – -11.1) 0.676
Secondary outcome
    Duration of MV, hour 254.3 (88.0 – 216.5) 303.5 (105.5 – 513.5) 0.145
    Reintubation, n (%) 3 (10.3) 2 (7.4) 0.767
    Tracheostomy, n (%) 7 (24.1) 6 (22.2) 0.991
    ICU mortality, n (%) 7 (24.1) 5 (18.5) 0.715
Data are expressed as median (interquartile range) unless otherwise noted. Tdiee, end-expiratory 
diaphragm thickness ; MV, mechanical ventilation ; ICU, intensive care unit.
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DISCUSSION
This study revealed four important findings. (1) Contrary 
to our hypothesis, Tdiee decreased over time in both groups 
and maximum variation in Tdiee was not associated with high 
proportion of controlled ventilation during early-phase of ACV. 
(2) Higher proportion of controlled ventilation during ACV was 
associated with higher set value for respiratory rate. (3) Despite 
higher plateau pressure and PEEP, tidal volume was significant-
ly less in the High group than in the Low group. (4) There was no 
significant intergroup difference in clinical outcomes.
The best established causal evidence for diaphragm myotrau-
ma is disuse atrophy (4, 5). Consequently, we focused on dia-
phragm inactivity during ACV, which is sometimes overlooked 
because respiratory muscle monitoring is not standard in most 
ICUs (22), and because every delivered breath during ACV looks 
the same (18). Marin-Corral et al, (19) recently compared the 
structural characteristics of diaphragms in brain-dead organ 
donors and Maastricht III organ donors who showed diaphrag-
matic stimulation. They found that Maastricht III organ donors 
presented less VIDD than brain-dead organ donors. Despite this 
histological evidence, we were unable to detect such adverse ef-
fects of controlled ventilation on patient diaphragms during ACV. 
In our study, we arbitrarily assigned patients to two groups with 
median CV48% : High, 53.8% ; and Low, 5.1%. We found that the 
proportion of assisted ventilation was 46.2% in High and 94.9% 
in Low. On the other hand, in the study by Marin-Corral et al., 
the median percentage of time in assisted and spontaneous 
modalities was 41% [IQR, 12 to 76] in Maastricht III donors and 
1% [IQR, 0 to 23] in brain-dead donors. Our different results are 
probably accounted for by greater diaphragm activity in our pa-
tients. Future studies may clarify the risk of diaphragm atrophy 
by revealing a clear cut-off value for CV48%.
Our findings are essentially consistent with two studies by 
Goligher et al. (3, 15) that show that diaphragm thickness de-
creases both during controlled modes of ventilation and during 
partially assisted ventilation. In one of these studies (15), con-
tractile activity decreased according to the number of days of 
controlled modes of ventilation. Moreover, in patients receiving 
controlled modes of ventilation, contractile activity was slightly 
but significantly greater if respiratory frequency was higher 
than the set rate. Even in PSV, high pressure levels of prolonged 
PSV developed diaphragm atrophy and contractile dysfunction 
(23). Such results suggested that presence of triggering, or oc-
currence of diaphragm activity in itself may not be sufficient to 
prevent diaphragm atrophy. Moreover, the protective effect of 
diaphragm contraction seems to depend on the amount of inspi-
ratory effort. Actually, we did not observe significant intergroup 
differences in inspiratory efforts represented by the thickening 
fraction. While we remain unsure what level of inspiratory effort 
is optimal, results from other investigations (3, 14, 24) suggest 
that the most effective approach may be to keep inspiratory ef-
fort similar to quiet breathing at rest. To do this, it is necessary 
to optimize ventilation settings and sedation level (25) and thus 
control neural respiratory drive.
In this study, Low group showed higher tidal volume in spite 
of lower driving pressure (plateau pressure minus PEEP). Be-
cause there was no intergroup difference in thickening fraction, 
Low group might have more of compliant lungs than increased 
inspiratory efforts. This was seen as one reason for lower tidal 
volume and higher PEEP in High group. In a recent animal 
study (26), lung protective ventilation with low tidal volume and 
high PEEP worsened VIDD by inducing oxidative stress and 
succeeding downregulation of peroxisome proliferator-activated 
receptor γ coactivator 1alpha (PGC-1α), reactive oxygen species 
inhibitor in diaphragm. This result is consistent with another 
study (27) showing that mechanical ventilation with a very 
large tidal volume of 35 mL / kg results in less oxidative stress 
in the diaphragm than ventilation with a moderate tidal volume 
of 9 mL / kg. Although the relationship between high PEEP 
and oxidative stress is unknown, excessive PEEP is associated 
with a rapid reduction in the number of sarcomeres and the 
Table 3.　Ventilation and physiological variables during the initial 48-hour period of assist-controlled ventilation
Variables Low group(N =  29)
High group
(N =  27)
P
Set respiratory rate, per min 13.6 (12.2 – 15.1) 16.4 (14.4 – 18.9) 0.003
Actual respiratory frequency, per min 18.7 (18.1 – 21.4) 17.7 (16.3 – 20.5) 0.245
CV48%, % 5.1 (1.6 – 13.7) 53.8 (36.4 – 61.6) < 0.001
Peak pressure, cm H2O 19.5 (17.4 – 21.9) 21.3 (19.0 – 23.2) 0.026
Plateau pressure, cm H2O 18.9 (16.7 – 21.4) 21.1 (18.9 – 22.7) 0.017
Positive end-expiratory pressure, cm H2O 7.8 (6.0 – 8.4) 8.0 (7.2 – 11.0) 0.030
Tidal volume, mL per kg PBW 9.1 (7.7 – 10.1) 7.8 (7.1 – 8.8) 0.029
FIO2, % 32 (25 – 39) 39 (29 – 51) 0.184
Arterial blood gas analysis ;
    pH 7.44 (7.41 – 7.47) 7.41 (7.34 – 7.43) 0.003
    PaCO2, mm Hg 35.3 (31.2 – 39.3) 40.4 (35.7 – 46.2) 0.352
    PaO2, mm Hg 88.1 (75.5 – 92.9) 91.5 (81.7 – 101.6) 0.220
    PaO2 / FIO2, mm Hg 269 (206 – 366) 269 (153 – 340) 0.533
Thickening fraction, % 12.5 (8.3 – 22.5) 17.4 (11.1 – 22.2) 0.367
Data are expressed as median (interquartile range). CV48% represents the proportion of controlled venti-
lation for the initial 48 hours of assist-control ventilation. CV, controlled ventilation ; PBW, predicted body 
weight.
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longitudinal atrophy of diaphragm fibers (28). Observing lower 
tidal volume and higher PEEP in the High group, we speculated 
that the VIDD developed in the High group might be worsened 
by incidental lung protective ventilation ; we did not detect, 
however, any detrimental effects. To prevent development of 
VIDD in clinical settings, further study may reveal what levels 
of tidal volume and PEEP are optimal during lung protective 
ventilation.
This study has several limitations. First, we employed previ-
ously used definition for proportion of controlled ventilation (15, 
19) assuming that all breaths were controlled breaths if actual 
respiratory frequency was equal to the set value for respiratory 
rate, and assisted breaths if actual frequency was greater than 
the set value. However, without detailed monitoring, this as-
sumption may not be always accurate. For example, there is the 
potential that patients are breathing spontaneously even if re-
spiratory frequency is equal to the set value. In this case, CV48% 
may be overestimated, especially when the set rate is high. 
Second, we focused on an initial 48-hour period of ACV, a dura-
tion that might be inadequate to detect the significant effects of 
controlled ventilation on the diaphragm. Even so, the 28 hours 
of controlled ventilation in the High group was within the range 
(18-69 hours) of the period of diaphragm inactivity in an autopsy 
study demonstrating rapid atrophy owing to disuse (9). Third, as 
mentioned above, according to the CV48% median value, we arbi-
trarily assigned patients to either of two groups and carried out 
intergroup comparison. As a result, we did not precisely find the 
discriminating cut-off value for CV48% ; we did not conduct this 
analysis because the sample population was small, especially the 
number of patients with very high CV48%. Fourth, since we stud-
ied only patients on pressure-control ACV, our findings cannot 
be applied to patients on volume-control ACV. Finally, since we 
studied adult mechanically ventilated patients with and with-
out respiratory failure, inspiratory efforts affecting diaphragm 
thickness were highly variable in our population. Future studies 
focused on patients with respiratory failure, who are at greater 
risk of VIDD, may have more useful clinical implications.
CONCLUSIONS
In a mixed population, the proportion of controlled ventilation 
more-than-or-equal-to 25% during early-phase ACV was not 
associated with maximum variation in diaphragm thickness 
detected by ultrasonography. More studies are required to un-
derstand how the degree and duration of diaphragm inactivity 
during ACV affects diaphragm atrophy.
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